COVID Symptom Study
COVID Symptom Study[edit | edit source]
The COVID Symptom Study is a large-scale research initiative aimed at understanding the symptoms and spread of COVID-19 through the use of a mobile application. The study was launched in March 2020 by ZOE, a health science company, in collaboration with King's College London and the NHS. The primary goal of the study is to track the symptoms of millions of users to identify potential outbreaks and understand the progression of the disease.
Background[edit | edit source]
The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has led to a global health crisis. Early detection and understanding of the disease's symptoms are crucial for controlling its spread. The COVID Symptom Study was developed to collect real-time data from the public to help researchers and healthcare professionals identify patterns and trends in the disease's manifestation.
Methodology[edit | edit source]
Participants in the study use the COVID Symptom Study app to report their health status daily. The app collects data on a wide range of symptoms, including common ones like fever, cough, and loss of smell, as well as less common symptoms. Users also report on their COVID-19 test results, if available.
The data collected is anonymized and analyzed by researchers to identify clusters of symptoms and potential new symptoms of COVID-19. The study has contributed to the understanding of "long COVID," a condition where symptoms persist for weeks or months after the initial infection.
Key Findings[edit | edit source]
The COVID Symptom Study has led to several important findings:
- Identification of loss of smell and taste as key symptoms of COVID-19.
- Recognition of "long COVID" and its various symptoms.
- Insights into the effectiveness of vaccines and the impact of new variants.
Impact[edit | edit source]
The study has provided valuable data to public health officials and has been used to inform policy decisions. It has also raised awareness about the diversity of COVID-19 symptoms and the importance of symptom tracking in managing the pandemic.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD